posted on 2024-03-12, 16:44authored byShaojun Yu, Jinrong Zheng, Haiting Xie, Qun Deng, Jianwei Wang, Jian Chen, Haitao Zhou, Jun Wang
Although the significance of the curative effect has
been recognized,
ideal nanocarriers with the properties of lysosomal escape and biocompatibility
are still lacking for the development of siRNA-based cancer gene therapy.
In this work, a lysosomal escaped and redox-responsive polyacrylamide
nanohydrogel (cRGD-9R-PAss) was constructed for STAT3 siRNA
delivery. The functional groups, including tumor-targeting peptide
cRGD, cell-penetrating and lysosome-escaping peptide 9R, and a redox-responsive
disulfide bond, were introduced to the polyacrylamide nanohydrogel
to attain enhanced transfection efficiency and biocompatibility. The
synthesized cRGD-9R-PAss(siRNA) was dispersed as core–shell
nanoparticles in water with an average size of 48 nm. cRGD-9R-PAss(siRNA) could prevent lysosomal phagocytosis and responsive
release STAT3 siRNA into C26 tumor cells, thus promoting STAT3 gene
silencing and inhibiting the proliferation of cancer cells in vitro
and in vivo. Our results demonstrate that cRGD-9R-PAss hydrogel
nanospheres constitute a potential candidate vector for siRNA-based
colon cancer gene therapy.